The U.S. Food and Drug Administration said it is aware that Nuwellis (NUWE) has issued a letter to affected health care providers recommending certain lots of AquaFlexFlow UF 500 Plus extracorporeal ...
The FDA is addressing a potentially high-risk issue linked to certain lots of the AquaFlexFlow UF 500 Plus extracorporeal blood circuit, a device produced by Nuwellis Inc (NASDAQ:NUWE). The device, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results